| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Medicine (E.O.A., A.H., J.E.C.), University of Cambridge School of Clinical Medicine, Cambridge; Medical Research Council Bone Research Laboratory (V.K., J.T.T.), Nuffield Orthopaedic Centre, Oxford, United Kingdom
Address all correspondence and requests for reprints to: Dr. J.E. Compston, Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrookes Hospital, Level 5, Box 157, Hills Road, Cambridge, CB2 2QQ United Kingdom.
Androgens have important effects on the human skeleton, and deficiency has been associated with bone loss in both males and females. The skeletal actions of androgens may be mediated directly via the androgen receptor (AR) or indirectly via the estrogen receptor after aromatization to estrogens. The presence of androgen receptors has been demonstrated in bone cells and chondrocytes in vitro, but their presence in human bone in situ has not been reported. In order to provide further evidence for a direct action of androgens on bone via androgen receptors, we have used specific monoclonal antibodies to investigate the expression of human AR in normal developing and osteophytic bone of both sexes.
In the growth plates from the developing bone, androgen receptors were predominantly expressed in hypertrophic chondrocytes and in osteoblasts at sites of bone formation. They were also observed in osteocytes in the bone, and in mononuclear cells and endothelial cells of blood vessels within the bone marrow. In the osteophytes, androgen receptors were widely distributed at sites of endochondral ossification in proliferating, mature, and hypertrophic chondrocytes and at sites of bone remodeling in osteoblasts. They were also expressed in osteocytes and mononuclear cells within the bone marrow. The pattern and number of cells expressing the receptor was similar in both sexes.
Our results show for the first time the presence and distribution of androgen receptors in normal developing human and osteophytic bone in situ and further provide evidence for a direct action of androgens on bone and cartilage cells.
This article has been cited by other articles:
![]() |
B. A. CROMER Menstrual Cycle and Bone Health in Adolescents Ann. N.Y. Acad. Sci., June 1, 2008; 1135(1): 196 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Godoy, A. Watts, P. Sotomayor, V. P. Montecinos, W. J. Huss, S. A. Onate, and G. J. Smith Androgen Receptor Is Causally Involved in the Homeostasis of the Human Prostate Endothelial Cell Endocrinology, June 1, 2008; 149(6): 2959 - 2969. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Bonjour and T. Chevalley Pubertal Timing, Peak Bone Mass and Fragility Fracture Risk IBMS BoneKEy, February 1, 2007; 4(2): 30 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vottero, S. Pedori, M. Verna, B. Pagano, M. Cappa, S. Loche, S. Bernasconi, and L. Ghizzoni Final Height in Girls with Central Idiopathic Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analog and Oxandrolone J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1284 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hero, E. Norjavaara, and L. Dunkel Inhibition of Estrogen Biosynthesis with a Potent Aromatase Inhibitor Increases Predicted Adult Height in Boys with Idiopathic Short Stature: A Randomized Controlled Trial J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6396 - 6402. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.M. Rivera-Woll, M. Papalia, S.R. Davis, and H.G. Burger Androgen insufficiency in women: diagnostic and therapeutic implications Hum. Reprod. Update, September 1, 2004; 10(5): 421 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. J. van der Eerden, M. Karperien, and J. M. Wit Systemic and Local Regulation of the Growth Plate Endocr. Rev., December 1, 2003; 24(6): 782 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Benito, B. Gomberg, F. W. Wehrli, R. H. Weening, B. Zemel, A. C. Wright, H. K. Song, A. Cucchiara, and P. J. Snyder Deterioration of Trabecular Architecture in Hypogonadal Men J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1497 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Issa, D. Schnabel, M. Feix, L. Wolf, H.-E. Schaefer, D. W. Russell, and H.-U. Schweikert Human Osteoblast-Like Cells Express Predominantly Steroid 5{alpha}-Reductase Type 1 J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5401 - 5407. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Miller, B. M. K. Biller, J. Hier, E. Arena, and A. Klibanski Androgens and Bone Density in Women with Hypopituitarism J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2770 - 2776. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hague, I.Z. MacKenzie, R. Bicknell, and M.C.P. Rees In-vivo angiogenesis and progestogens Hum. Reprod., March 1, 2002; 17(3): 786 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Miller Androgen Deficiency in Women J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2395 - 2401. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Fairfield, J. S. Finkelstein, A. Klibanski, and S. K. Grinspoon Osteopenia in Eugonadal Men with Acquired Immune Deficiency Syndrome Wasting Syndrome J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2020 - 2026. [Abstract] [Full Text] |
||||
![]() |
K. K. Miller, G. Sesmilo, A. Schiller, D. Schoenfeld, S. Burton, and A. Klibanski Androgen Deficiency in Women with Hypopituitarism J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 561 - 567. [Abstract] [Full Text] |
||||
![]() |
G. M Prelevic Osteoporosis in men J R Soc Med, January 12, 2001; 94(12): 620 - 623. [Full Text] [PDF] |
||||
![]() |
J. E. Compston Sex Steroids and Bone Physiol Rev, January 1, 2001; 81(1): 419 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Soyka, W. P. Fairfield, and A. Klibanski Hormonal Determinants and Disorders of Peak Bone Mass in Children J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 3951 - 3963. [Full Text] |
||||
![]() |
R. Marcus, D. Leary, D. L. Schneider, E. Shane, M. Favus, and C. A. Quigley The Contribution of Testosterone to Skeletal Development and Maintenance: Lessons from the Androgen Insensitivity Syndrome J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1032 - 1037. [Abstract] [Full Text] |
||||
![]() |
E. Barrett-Connor, J. E. Mueller, D. G. von Mühlen, G. A. Laughlin, D. L. Schneider, and D. J. Sartoris Low Levels of Estradiol Are Associated with Vertebral Fractures in Older Men, But Not Women: The Rancho Bernardo Study J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 219 - 223. [Abstract] [Full Text] |
||||
![]() |
J. Van Wyk Insulin-Like Growth Factors and Skeletal Growth: Possibilities for Therapeutic Interventions J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4349 - 4354. [Full Text] |
||||
![]() |
Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4677 - 4694. [Abstract] [Full Text] |
||||
![]() |
K. Wiren, E. Keenan, X. Zhang, B. Ramsey, and E. Orwoll Homologous Androgen Receptor Up-Regulation in Osteoblastic Cells May Be Associated with Enhanced Functional Androgen Responsiveness Endocrinology, July 1, 1999; 140(7): 3114 - 3124. [Abstract] [Full Text] |
||||
![]() |
C. Wang, A. Iranmanesh, N. Berman, V. McDonald, B. Steiner, F. Ziel, S. M. Faulkner, R. E. Dudley, J. D. Veldhuis, and R. S. Swerdloff Comparative Pharmacokinetics of Three Doses of Percutaneous Dihydrotestosterone Gel in Healthy Elderly Men-A Clinical Research Center Study J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2749 - 2757. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |